0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurotransmitter"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$4,650USDGBP
Sleep Disorders Treatment: Global Market Outlook - Product Thumbnail Image

Sleep Disorders Treatment: Global Market Outlook

  • Report
  • March 2023
  • 57 Pages
  • Global
From
EUR$2,500USDGBP
From
EUR$6,499USDGBP
From
EUR$6,499USDGBP
From
EUR$6,499USDGBP
From
EUR$6,499USDGBP
From
EUR$6,499USDGBP
From
EUR$6,499USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$7,950USDGBP
Epilepsy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Epilepsy - Epidemiology Forecast - 2032

  • Report
  • January 2024
  • 197 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$7,500USDGBP
United States AUSTEDO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States AUSTEDO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • United States
From
EUR$2,750USDGBP
Ingrezza Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Ingrezza Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
EUR$3,250USDGBP
From
EUR$2,750USDGBP
Loading Indicator

The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain. The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more